NATICK, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in U.S. District Court in San Francisco has found that Boston Scientific infringes a patent of Cordis Corporation, a subsidiary of Johnson & Johnson, under the doctrine of equivalents. The Company said it believes the finding of infringement is in error and that it will request the judge to overturn it.
No damages were determined because the judge found that Cordis failed to submit evidence sufficient to enable a jury to make a damage assessment. The jury also found invalid four Boston Scientific patents that were infringed by Cordis.
The patents in the case involve balloon catheter technology.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.
Cautionary Statement Regarding Forward Looking Statements
This press release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements may be identified by words like "anticipate,"
"expect," "project," "believe," "plan," "estimate," "intend" and similar
words. These forward- looking statements are based on our beliefs,
assumptions and estimates using information available to us at the time and
are not intended to be guarantees of future events or performance. These
forward-looking statements include, among other things, statements
regarding intellectual property litigation and competitive offerings. If
our underl
'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2007 PR Newswire. All rights reserved |